OBJ 4.17% 2.3¢ obj limited

Novartis.

  1. 800 Posts.
    lightbulb Created with Sketch. 2
    GSK analgesics signed JV with Novartis.
    Obj meetings with GSK A. scheduled this quarter.



    Novartis. Powerhouse. Diclofenac (Voltaren) a product they have.




    OBJ 16/9/2005. Clinical test on our tech increasing uptake of Novartis' diclofenac (Voltaren).

    Yielded great results.

    A decade later. The opportunity presents.



 
watchlist Created with Sketch. Add OBJ (ASX) to my watchlist
(20min delay)
Last
2.3¢
Change
-0.00(4.17%)
Mkt cap $41.61M
Open High Low Value Volume
2.2¢ 2.4¢ 2.2¢ $65.91K 2.887M

Buyers (Bids)

No. Vol. Price($)
1 11200 2.3¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 400000 2
Last update - 13.17pm 19/10/2018 (20 minute delay) ?
(live)
Last
2.3¢
  Change
-0.00 ( 4.17 %)
Open High   Low Volume
2.2¢ 2.3¢   2.2¢ 577600
Last updated 12.07pm 19/10/2018 (live) ?
OBJ (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.